Non-Invasive Prenatal Testing Market Expected to Reach USD 8.75 Billion by 2027 | Study by Emergen Research

Emerging research logo

Non-Invasive Prenatal Testing Market Trends – High Demand from Developing Countries.

Non-Invasive Prenatal Testing Market Size – USD 3.08 Billion in 2019, Market Growth – CAGR of 13.9%, Non-Invasive Prenatal Testing Market Trends – High Demand from Developing Countries”

— Emerging research

VANCOUVER, BC, CANADA, June 22, 2022 / —
The global noninvasive prenatal testing market is expected to reach $8.75 billion by 2027, according to a new report from Emergen Research. The non-invasive prenatal test (NIPT), commonly referred to as cell-free DNA testing, is considered a significant extension of the variety of diagnostic methods used to detect fetal chromosomal abnormalities. NIPT is also considered superior to other screening modalities, especially for trisomy 21 (one of the most common birth defects). NIPT allows individuals to make informed decisions about whether diagnostic tests should be performed. Associated fetal chromosomal abnormalities usually include the benefit or absence of genetic material which may differ from small segments to small segments of chromosomes to whole chromosomes.

The Global Non-Invasive Prenatal Testing Market report from Emergen Research is the latest document covering changes in market dynamics and trends following the COVID-19 outbreak. The global health emergency has brought about unprecedented changes in the global economic scenario, drastically affecting the landscape of the non-invasive prenatal test market, disrupting its supply chains and causing volatility in product prices and demand. The report analyzes the impact of the pandemic on the Non-Invasive Prenatal Testing industry and highlights its beleaguered segments. However, our analysts believe that the market will regain ground in the post-COVID scenario.

To receive a sample of the Global Non-Invasive Prenatal Testing Market Report, click here @

Other key findings from the report suggest

Based on the method, Ultrasonic Detection generated revenue of USD 0.86 billion in 2019 and is expected to grow with a CAGR of 14.0% during the forecast period, owing to capacity from ultrasound diagnostics to detecting abnormalities in the baby’s position and actions. in the womb.
The hospital segment is expected to grow with a CAGR of 14.1% over the forecast period owing to the increasing introduction of non-invasive prenatal tests coupled with rapid technological developments and breakthrough acceptance strategies.
The trisomy app is the leading contributor to the non-invasive prenatal testing market. The North America region Down syndrome application is the largest market shareholder and held approximately 45.1% of the market in 2019, due to the high incidence of genetic disorders correlated with Down syndrome, such as Patau syndrome, Down syndrome and Edward syndrome.

Global Non-Invasive Prenatal Testing Market Report – Segment Analysis:

The global non-invasive prenatal testing market vertical has been broadly categorized based on product type, range of applications, end-user industries, and competitive overview. The report examines the current market scenario, its past performance, demand and supply ratios, production and consumption rates, sales, and numerous growth opportunities available in the market. It further estimates the potential growth of key regional segments of the market, which is beneficial for the readers to gain insightful insights into the Non-Invasive Prenatal Testing business sector. A clear overview of the competitive landscape of the market should help companies involved in this sector to decipher the optimal business moves to achieve their desired business goals.

For Key Market Insights, Visit the Link Below:

For the purposes of this report, Emergen Research has segmented the global non-invasive prenatal testing market based on method, end-use, application, and region:

Method Outlook (Revenue, USD Billion; 2017-2027)
Ultrasonic detection
Biochemical screening tests
Cell-Free DNA in Maternal Plasma Tests

End-Use Outlook (Revenue, USD Billion; 2017-2027)
Diagnostic laboratories
Research centers

Application Outlook (Revenue, USD Billion; 2017-2027)
Microdeletion syndrome

Key Geographies Featured in the Report:
North America (United States, Mexico and Canada)
Asia-Pacific (China, Japan, India and Rest of Asia-Pacific)
Europe (UK, France, Germany and Rest of Europe)
Latin America (Brazil and rest of Latin America)
Middle East and Africa (GCC Countries and Rest of Middle East and Africa)

Competitive outlook:
This section of the report conducts an in-depth investigation of the fiercely competitive landscape of the global Non-Invasive Prenatal Testing Market, highlighting the major manufacturers, strategic initiatives adopted by them, existing growth prospects, market positions and shares market held by each participant. . The report places more emphasis on the development strategies undertaken by these companies, including product innovation, new product launch, and technology upgrading. Moreover, the report studies notable business events observed in this industry such as mergers and acquisitions, joint ventures, partnerships, corporate agreements, and brand promotions.

Key industry participants include:

Yourgene Health, Illumina Inc., Agilent Technologies Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Laboratory Corporation of America Holdings, GE Healthcare, PerkinElmer Inc., BGI, and Natera Inc., among others.

Request Exclusive Report Discount @

Key Objectives of the Global Non-Invasive Prenatal Testing Market Report:

An overall analysis and forecast estimate of the market has been included in this report.
The report offers valuable insights into key drivers, restraints, opportunities, and challenges faced by the global Non-Invasive Prenatal Testing Market and its key players.
The report sheds light on the leading market competitors along with their business strategies and long-term expansion plans.

Access Full Report Description @

The report further presents a comprehensive analysis of key elements of the Non-Invasive Prenatal Testing market that influence its growth over the projected period. These vital elements include key drivers, constraints, opportunities, limitations, threats, and micro and macro factors. The report authors have implemented a set of analytical tools, such as SWOT analysis, Porter’s five forces analysis, feasibility analysis, and ROI analysis to come up with strategic recommendations to new entrants on how to overcome entry-level barriers.

Request Market Report Customization @

Thank you for reading our report. To learn more about the report or for any questions about customizing the report, please contact us. We will ensure that our team provides the necessary assistance and designs your report according to your requirements.

Explore more Emergen Research Reports @

Industrial Control System Security Market-

Brachytherapy Market-

3D Printing Metal Market-

Cloud Data Backup Recovery Market-

Insulation Materials Market-

Surface Treatment Chemicals Market-

Microgrid Market-

About Us:

Emergen Research is a market research and consulting firm that provides syndicated research reports, custom research reports, and consulting services. Our solutions are uniquely focused on your goal of locating, targeting and analyzing changes in consumer behavior across demographics, across industries, and helping customers make smarter business decisions. We offer market intelligence research ensuring relevant and factual research across multiple sectors including health, touchpoints, chemicals, types and energy. We are constantly updating our search offerings to ensure that our clients are aware of the latest trends existing in the market. Emergen Research has a strong base of experienced analysts from a variety of areas of expertise. Our industry experience and ability to develop a workable solution to any research problem gives our clients the ability to secure an edge over their respective competitors.

Read Full Press Release @

Contact us:

Eric Lee
Emerging research
+91 90210 91709
write to us here
Visit us on social media:

Size of the non-invasive prenatal testing market worth USD 8.75 billion by 2027

Comments are closed.